Uranium Royalty Corp (NASDAQ: UROY) stock fell -0.34% on Monday to $2.95 against a previous-day closing price of $2.96. With 1.2 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.41 million shares. The 52-week range on UROY shows that it touched its highest point at $3.29 and its lowest point at $1.81 during that stretch. It currently has a 1-year price target of $5.42. Beta for the stock currently stands at 1.70.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UROY was up-trending over the past week, with a rise of 4.24%, but this was up by 6.88% over a month. Three-month performance surged to 26.07% while six-month performance rose 46.77%. The stock gained 9.67% in the past year, while it has gained 24.47% so far this year.
Float and Shares Shorts:
At present, 99.80 million UROY shares are outstanding with a float of 81.22 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.74 million, which was 1.72% higher than short shares on Sep 28, 2023. In addition to Mr. Scott Eric Melbye as the firm’s CEO, President & Director, Ms. Josephine Man serves as its Chief Financial Officer.
Through their ownership of 16.76% of UROY’s outstanding shares, institutional investors have minority control over the company. With a 4.54% stake in UROY, the Global X Uranium ETF is the largest stakeholder. A total of 4,592,902 shares are owned by the mutual fund manager. The Sprott Uranium Miners ETF, which owns about 4.31% of UROY stock, is the second-largest Mutual Fund holder. It holds 4,356,879 shares valued at 12.46 million. Sprott Junior Uranium Miners ETF holds 1.35% of the stake in UROY, owning 1,365,016 shares worth 3.9 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UROY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With UROY analysts setting a high price target of $6.20 and a low target of $4.63, the average target price over the next 12 months is $5.42. Based on these targets, UROY could surge 110.17% to reach the target high and rise by 56.95% to reach the target low. Reaching the average price target will result in a growth of 83.73% from current levels.